Abstract
Objectives To develop a toolkit to provide a structured framework for assessing whether large events are COVID-secure.
Study design Cross-sectional reporting on the development of the COVID-19 Suffolk Events Toolkit (C-SET).
Methods The toolkit was developed through an iterative process of writing, discussion, and modification, drawing upon national UK guidance. Pilot cases and a contemporaneous consultation with experts were also undertaken, and C-SET was revised in line with the findings.
Results C-SET offers a robust, structured approach to identifying areas of concern and potential mitigations, and collates and synthesises current national UK guidance. A flexible, modular design allows it to provide high-level input across all types of event, and allow modification to suit the needs of individual organisations. It is applicable to a variety of users, including event organisers in need of a structure, or bodies whose role is to appraise such events. It provides a semi-quantitative summary output, and in conjunction with the detailed links to guidance in the framework, allows development of clear, actionable recommendations to tangibly improve the quality of events.
Conclusions A necessary trade-off exists between COVID-related health risks and wider risks due to economic downturn, and facilitating large events in a way that minimises COVID transmission risk may offer a way to balance these competing priorities. C-SET was developed to provide a structured approach to identifying areas of improvement across key risk domains, and suggests potential mitigations that are underpinned by national UK guidance. Use of this toolkit may aid event organisers in developing COVID-secure events, and aid regulatory bodies in suggesting actionable recommendations through generation of a summary report of areas of concern.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No direct patient identifiable data was used in this work.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant source material is available via hyperlink in supplementary material.
